Mechanisms Underlying the Improvement of Insulin Resistance in Response to Bariatric Surgery
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 42
- 试验地点
- 2
- 主要终点
- fasting insulin
研究概览
简要总结
Non-randomized open label study to investigate factors mediating changes in insulin sensitivity, glucose tolerance and other metabolic outcomes after bariatric surgery.
详细描述
Bariatric and weight loss surgery is an effective treatment for severe obesity. Bariatric surgery also decreases insulin resistance and improves diabetes. Our study enrolled individuals approved for bariatric surgery to collect data on modifiable predictors and laboratory outcomes. These data would allow us to systematically assess clinical outcomes over one year post bariatric surgery and elucidate how insulin resistance is decreased and diabetes is improved.
The type of surgery was selected by the subjects between Roux-en-Y gastric bypass or a laparoscopic adjustable gastric banding. Participation in the study involved having a small sample of tissue obtained from the abdomen and subjects were also given the option to have a biopsy performed in the thigh area during their elective surgical procedure (optional adipose and muscle tissue biopsies).
Subjects were examined prior to surgery and at 2, 3, 6 months after intervention. Anthropometric and body composition measurements were performed using the Bioelectrical Impendence Analysis (BIA) before surgery and 6 months post operatively. Morning blood was collected after overnight fasting during each visit. Some of the non-diabetic subjects completed a mixed nutrient stimulation study during the baseline and 6-month visit. Blood samples were collected immediately prior to drinking the liquid drink, and every 30 minutes after the meal ingestion for 2 hours.
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Parallel
- 主要目的
- Basic Science
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 65 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •males and females
- •18-65 years old
- •approved for bariatric surgery as per BIDMC Bariatric Clinic guidelines
- •English-speaking
- •willing and able to take part in a multi year study involving telephone interviews and enrolled prior to bariatric surgery
排除标准
- •Any condition that would exclude a patient from bariatric surgery as listed below:
- •patients with untreated major depression or psychosis
- •binge eating disorders
- •current drug and alcohol abuse
- •severe cardiac disease with prohibitive anesthetic risks
- •severe coagulopathy
- •inability to comply with nutritional requirements including life-long vitamin replacement.
- •Any additional condition not in accordance with standard of care as per Bariatric Clinic at BIDMC.
- •Any condition which in the opinion of the investigators rendered the candidate unsuitable for participation in this study.
- •Exclusion Criteria for Optional Biopsy:
- •history of any illness, other than obesity, that may affect insulin sensitivity (diabetes anemia, infectious diseases, renal or hepatic failure, uncontrolled hypertension, cancer or lymphoma)
- •subjects who required special diet prior to surgery
- •chronic inflammatory conditions such as inflammatory bowel disease and rheumatoid arthritis
- •states of cortisol or growth hormone excess
- •any medications that are known to influence glucose metabolism such as glucocorticoids
- •a known history of anaphylaxis or anaphylactoid-like reactions or who have a known hypersensitivity to anesthetic agents such as Lidocaine or Novocaine
- •a known history of bleeding dyscrasia or poor wound healing
- •any medical condition precluding supine position
结局指标
主要结局
fasting insulin
时间窗: Change from Baseline insulin at 6 months post-surgery
circulating levels of fasting insulin measured in pmol/L
Boost Challenge Test
时间窗: Change from Baseline insulin at 6 months post-surgery
serum insulin and glucose levels after a mixed meal challenge (Boost Protein shake)
fasting glucose
时间窗: Change from Baseline insulin at 6 months post-surgery
circulating levels of fasting glucose measured in mg/dl
次要结局
未报告次要终点
研究者
Christos Mantzoros
Principal Investigator
Beth Israel Deaconess Medical Center